DewDiligence & McBio: Switching my tracking of Medivir to the Stockholm Exchange is not a post hoc change. In the past, when there’s a clear primary exchange where a stock is traded, I’ve always tracked the stock on that exchange.
According to Yahoo finance, the average 3 month trading volume for Medivir on the Stockholm exchange under the MVIR-B.ST symbol is 114,203 shares. In contrast, the average 3 month Pink Sheet trading volume for Medivir under the MVRBF.PK symbol is 37 shares. And the last Pink Sheet trading was on 12/19/11 for a grand total of 200 shares. Given that disparity, does it really make sense to use the Pink Sheet symbol to track Medivir?
Remember, this is a charity contest! The winner gets to pick a charity! In the original rules, I wrote: “Late portfolio posters will have the advantage of knowing the first week's price changes. Please don't abuse this advantage when choosing your portfolio stocks.” Nonetheless, a few contestants apparently ignored my request. So, after asking for comments on what to do, I changed the rules to make the Contest fairer although it meant extra work for me.
Even with the rule changes, because of the BMY buyout offer for INHX over the past weekend, late Contest entrants had the advantage of selecting other biotechs with promising Hep-C drugs. And two late entries did allocate 20% of their portfolios to ACHN. Although I got complaints about this, not wanting another hassle, I didn’t bring it up as an issue.
However, although I think it makes no sense to use the Pink Sheets to track Medivir and the chances it will make a difference in the outcome of the Contest are minuscule, I’ll do what the majority of contestants favor.
Peace & good health,
Bulba |
